[1]
H. M. E. Arshad, F. Ali, A. Babar, M. Z. Raza, M. Maqsood, and A. Ameer, “Survival impact and safety comparison of pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A meta-analysis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 42, no. 3, p. 16432, Sep. 2025, doi: 10.36141/svdld.v42i3.16432.